CMND Stock Analysis: Buy, Sell, or Hold?
CMND - Clearmind Medicine Inc. Common Shares
$5.92
-0.22 (-3.58%)
âŧ
5d:
-0.79%
30d:
-1.33%
90d:
+236.36%
WAIT
LOW Confidence
Analysis Updated: Nov 3, 2026 12:00 AM ET
Earnings: Sep 10, 2026
0d
Get Alerted When CMND Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CMND is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CMND is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CMND is currently trading at $5.92, which is considered fair relative to its 30-day fair value range of $2.79 to $7.23.
Technical Outlook: Technically, CMND is in a uptrend. Immediate support is located at $5.43, while resistance sits at $6.50. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: CMND scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CMND is in a uptrend. Immediate support is located at $5.43, while resistance sits at $6.50. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: CMND scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.79 -
$7.23
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
38.2%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.79 -
$7.23
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.43
Resistance Level
$6.50
Current Trend
Uptrend
Technical data as of
Nov 3, 2026
Fundamental Context
Share & Embed Analysis
Last updated: November 03, 2026 8:39 PM ET
Data refreshes hourly during market hours. Next update: 9:39 PM
Data refreshes hourly during market hours. Next update: 9:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMND showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 44 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
GPCR
Structure Therapeutics IâĻ |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 58 HOLD |
